Excessive Daytime Sleepiness: Clinical Trials

1 trial for Excessive Daytime Sleepiness, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Recruiting 1

Follow Excessive Daytime Sleepiness: new trials by email Literature Review of Excessive Daytime Sleepiness trials Research Report on Excessive Daytime Sleepiness

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of ORX142 in Healthy Adult Subjects, Including Subjects 18 to 80 Years of Age
ORX142 Tablets, Placebo Tablets - Excessive Daytime Sleepiness
Phase 1RecruitingCentessa Pharmaceuticals (UK) Limited2082025-06-302025-12-24

Narrower conditions

Disorders of Excessive Somnolence (1)

Broader conditions

Dyssomnias (1)  ·  Mental Disorders (1)  ·  Nervous System Diseases (1)  ·  Sleep Disorders, Intrinsic (1)  ·  Sleep Wake Disorders (1)

Sponsors

Centessa Pharmaceuticals (UK) Limited (1)

Countries

United States (1)